Evid Invest
Who owns REGNWhat REGN owns

What REGENERON PHARMACEUTICALS, INC. owns

The company's own 13F portfolio · as of 2026-06-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F

$177.2M

disclosed stock portfolio

3

positions

64.4%

in PBLS

Positions, as of 2026-06-30

ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1PBLSParabilis Medicines, Inc.4.2M$114.0M64.4%
2NTLAIntellia Therapeutics, Inc.3.7M$62.7M35.4%
3ACETAdicet Bio, Inc.60,511$522,8190.3%

Source: SEC Form 13F-HR filed by REGENERON PHARMACEUTICALS, INC. (CIK 872589), reporting period 2026-06-30. Values are quarter-end filed marks. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.